PRTA
Price
$6.68
Change
-$0.02 (-0.30%)
Updated
Jul 25 closing price
Capitalization
359.56M
11 days until earnings call
PYPD
Price
$3.68
Change
-$0.06 (-1.60%)
Updated
Jul 25 closing price
Capitalization
37.5M
10 days until earnings call
Interact to see
Advertisement

PRTA vs PYPD

Header iconPRTA vs PYPD Comparison
Open Charts PRTA vs PYPDBanner chart's image
Prothena
Price$6.68
Change-$0.02 (-0.30%)
Volume$772.13K
Capitalization359.56M
PolyPid
Price$3.68
Change-$0.06 (-1.60%)
Volume$23.54K
Capitalization37.5M
PRTA vs PYPD Comparison Chart in %
Loading...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTA vs. PYPD commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTA is a Buy and PYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (PRTA: $6.68 vs. PYPD: $3.68)
Brand notoriety: PRTA and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTA: 45% vs. PYPD: 3%
Market capitalization -- PRTA: $359.56M vs. PYPD: $37.5M
PRTA [@Biotechnology] is valued at $359.56M. PYPD’s [@Biotechnology] market capitalization is $37.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTA’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • PRTA’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRTA’s TA Score shows that 5 TA indicator(s) are bullish while PYPD’s TA Score has 5 bullish TA indicator(s).

  • PRTA’s TA Score: 5 bullish, 3 bearish.
  • PYPD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than PYPD.

Price Growth

PRTA (@Biotechnology) experienced а +6.71% price change this week, while PYPD (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

PRTA is expected to report earnings on Aug 07, 2025.

PYPD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($360M) has a higher market cap than PYPD($37.5M). PYPD YTD gains are higher at: 21.053 vs. PRTA (-51.769). PYPD has higher annual earnings (EBITDA): -29.31M vs. PRTA (-137.71M). PRTA has more cash in the bank: 418M vs. PYPD (8.04M). PYPD has less debt than PRTA: PYPD (8.83M) vs PRTA (10.2M). PRTA has higher revenues than PYPD: PRTA (138M) vs PYPD (0).
PRTAPYPDPRTA / PYPD
Capitalization360M37.5M960%
EBITDA-137.71M-29.31M470%
Gain YTD-51.76921.053-246%
P/E RatioN/AN/A-
Revenue138M0-
Total Cash418M8.04M5,200%
Total Debt10.2M8.83M116%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRTAPYPD
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLA10.130.55
+5.74%
Stellantis NV
FDP35.630.37
+1.05%
Fresh Del Monte Produce
RITM12.19-0.04
-0.33%
Rithm Capital Corp
JBIO8.28-0.05
-0.60%
Jade Biosciences Inc
AGMH2.45-0.02
-0.81%
AGM Group Holdings Inc

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
-0.30%
RCKT - PRTA
54%
Loosely correlated
-2.18%
SVRA - PRTA
46%
Loosely correlated
+1.18%
DNLI - PRTA
42%
Loosely correlated
-4.47%
KRYS - PRTA
39%
Loosely correlated
-1.59%
CLDX - PRTA
37%
Loosely correlated
+0.56%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
-1.60%
ELEV - PYPD
30%
Poorly correlated
N/A
MESO - PYPD
29%
Poorly correlated
-3.65%
PRTA - PYPD
26%
Poorly correlated
-0.30%
ASPHF - PYPD
24%
Poorly correlated
N/A
TENX - PYPD
23%
Poorly correlated
-0.98%
More